Month: September 2024

Clouds of Care Secures 5 Million Euros to Propel CNS Healthcare Innovation and appoints former CEO of Biogen, Michel Vounatsos, as chairman of the board of directors

GHENT, Belgium, Sept. 4, 2024 /PRNewswire/ -- Clouds of Care, a leading MedTech company dedicated to enabling better care for people with...

Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study

Multicenter Clinical Study Demonstrates Benefits of Regenity's Novel Crosslinked Collagen Membrane Compared to Geistlich Bio-Gide® Collagen Membrane and Enables Launch...

Phesi Receives Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform

Phesi's Trial Accelerator™ Platform empowers trial sponsors to make informed decisions swiftly, expediting drug development timelines while upholding the highest...

Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)

HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that...

HealthVerity introduces taXOnomy℠, the nation’s most comprehensive closed (X) and open (O) claims dataset for pharmaceutical research

PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the...

error: Content is protected !!